5-80654720-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002439.5(MSH3):c.-8G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,593,122 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 1 hom. )
Consequence
MSH3
NM_002439.5 5_prime_UTR
NM_002439.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.854
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
DHFR (HGNC:2861): (dihydrofolate reductase) Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 5-80654720-G-T is Benign according to our data. Variant chr5-80654720-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1704343.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 13 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH3 | NM_002439.5 | c.-8G>T | 5_prime_UTR_variant | 1/24 | ENST00000265081.7 | NP_002430.3 | ||
DHFR | NM_000791.4 | c.-231C>A | 5_prime_UTR_variant | 1/6 | ENST00000439211.7 | NP_000782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081 | c.-8G>T | 5_prime_UTR_variant | 1/24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
DHFR | ENST00000439211.7 | c.-231C>A | 5_prime_UTR_variant | 1/6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000667069 | c.-8G>T | 5_prime_UTR_variant | 1/22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000670357.1 | n.-8G>T | non_coding_transcript_exon_variant | 1/25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-8G>T | 5_prime_UTR_variant | 1/25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes AF: 0.0000857 AC: 13AN: 151762Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
151762
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000313 AC: 7AN: 223626Hom.: 0 AF XY: 0.0000323 AC XY: 4AN XY: 123648
GnomAD3 exomes
AF:
AC:
7
AN:
223626
Hom.:
AF XY:
AC XY:
4
AN XY:
123648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000430 AC: 62AN: 1441256Hom.: 1 Cov.: 34 AF XY: 0.0000418 AC XY: 30AN XY: 717496
GnomAD4 exome
AF:
AC:
62
AN:
1441256
Hom.:
Cov.:
34
AF XY:
AC XY:
30
AN XY:
717496
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151866Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74230
GnomAD4 genome
AF:
AC:
13
AN:
151866
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Mar 10, 2023 | This variant has not been reported in the published literature. The frequency of this variant in the general population, 0.000051 (6/117336 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. Based on the available information, we are unable to determine the clinical significance of this variant. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at